Literature DB >> 20098576

The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patients.

Krzysztof Laudanski1, Huma Ali, Andrew Himmel, Kasia Godula, Mary Stettmeier, Lisa Calvocoressi.   

Abstract

BACKGROUND: Cardiac arrhythmias are common comorbidities among acutely ill patients admitted to hospitals. An abnormal iron metabolism may contribute to the abnormalities in the conduction and propagation of action potentials through myocardium.
OBJECTIVE: To determine whether serum indexes of iron metabolism correlate with electrocardiogram (ECG) changes.
METHODS: In the present retrospective, pilot chart review, serum levels of iron, ferritin, Na(+), K(+), Mg(2+), Ca(2+) and total iron-binding capacity in 77 hospitalized patients with acute illness were correlated with ECG variables.
RESULTS: The serum ferritin level correlated strongly (r=0.49) with QT/QTs interval. There were three subjects with QT prolongation (longer than 450 ms) within the high serum ferritin (576 ng/mL or greater) group versus subjects with low ferritin. Multiple regression analysis showed that serum ferritin level and serum iron level contributed to the variance in the QT/QTs prolongation. No other correlation between the studied serum markers and ECG characteristics were found.
CONCLUSION: The present study suggests that serum ferritin and iron levels affect the QT interval in a variety of medical conditions, possibly contributing to the emergence of fatal cardiac arrhythmias.

Entities:  

Keywords:  Arrhythmia; Long QT; Serum ferritin; Serum iron

Year:  2009        PMID: 20098576      PMCID: PMC2807778     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  23 in total

1.  Novel roles for nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function.

Authors:  Michael S Wolin; Sachin A Gupte
Journal:  Circ Res       Date:  2005-09-30       Impact factor: 17.367

Review 2.  What is QT interval prolongation?

Authors:  David A Vorchheimer
Journal:  J Fam Pract       Date:  2005-06       Impact factor: 0.493

Review 3.  Short QT syndrome.

Authors:  Ramon Brugada; Kui Hong; Jonathan M Cordeiro; Robert Dumaine
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

Review 4.  Hemochromatosis: genetics and pathophysiology.

Authors:  Ernest Beutler
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

5.  The epidemiology of hyperferritinaemia.

Authors:  Sarah Hearnshaw; Nick-Paul Thompson; Andrew McGill
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

6.  Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy.

Authors:  Carlos A Obejero-Paz; Tianen Yang; Wei-Qiang Dong; Matthew N Levy; Gary M Brittenham; Yuri A Kuryshev; Arthur M Brown
Journal:  J Lab Clin Med       Date:  2003-02

7.  Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium.

Authors:  D H Fitchett; D J Coltart; W A Littler; M J Leyland; T Trueman; D I Gozzard; T J Peters
Journal:  Cardiovasc Res       Date:  1980-12       Impact factor: 10.787

8.  Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation.

Authors:  H Miskin; I Yaniv; M Berant; C Hershko; H Tamary
Journal:  Eur J Haematol       Date:  2003-06       Impact factor: 2.997

9.  The relationship between iron stores and corrected QT dispersion in patients undergoing hemodialysis.

Authors:  Erkan Dervişoğlu; Ahmet Yilmaz; Erce Sevin; Betül Kalender
Journal:  Anadolu Kardiyol Derg       Date:  2007-09

10.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

View more
  1 in total

1.  Common founder effects of hereditary hemochromatosis, Wilson´s disease, the long QT syndrome and autosomal recessive deafness caused by two novel mutations in the WHRN and TMC1 genes.

Authors:  K Sigvard Olsson; Olof Wålinder; Ulf Jansson; Maria Wilbe; Marie-Louise Bondeson; Eva-Lena Stattin; Ruma Raha-Chowdhury; Roger Williams
Journal:  Hereditas       Date:  2017-12-19       Impact factor: 3.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.